Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes

Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes

Background Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TILs) is a promising experimental immunotherapy that has shown high objective responses in patients with melanoma. Current protocols use a lymphodepletive chemotherapy before infusion of ex vivo expanded TILs, followed by h...

Full description

Saved in:
Bibliographic Details
Main Authors: Thierry Kuntzer, Olivier Michielin, George Coukos, Alexandre Harari, Stefan Zimmermann, Maria Ochoa de Olza, Denis Comte, Angela Orcurto, Andreas Hottinger, Benita Wolf, Blanca Navarro Rodrigo, Aymeric Auger, Virginie Zimmer, Philippe Gannon, Lana Kandalaft, Lionel Trueb
Format: Article
Language:English
Published: BMJ Publishing Group 2020-10-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e001155.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jitc.bmj.com/content/8/2/e001155.full

Similar Items